HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial-Reference-Cited by-同舟云学术

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

Published:2010-07 Issue:9738 Volume:376 Page:333-339
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ridker Paul M,Genest Jacques,Boekholdt S Matthijs,Libby Peter,Gotto Antonio M,Nordestgaard Børge G,Mora Samia,MacFadyen Jean G,Glynn Robert J,Kastelein John JP

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N Engl J Med,1996

3. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial;Lancet,2002

4. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995

5. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS;Downs;JAMA,1998

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between High-Sensitivity C-Reactive Protein (hs-CRP) Levels With Lipids and Micronutrients;Cureus;2024-08-20

2. Recent Advances in Targeted Management of Inflammation In Atherosclerosis: A Narrative Review;Cardiology and Therapy;2024-07-20

3. Effects of Diabetes and Hyperlipidemia in Physiological Conditions - A Review;Current Diabetes Reviews;2024-02-23

4. Residual Cardiovascular Risk Determined through Posthoc Analysis of the REAL-CAD Trial;Journal of Atherosclerosis and Thrombosis;2024-01-01

5. Special Patient Populations;Clinical Lipidology;2024